research advances in cystic fibrosis expert interpretations and clinical insights
DESCRIPTION
Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights. Data on Nebulized Levofloxacin and Guidance on Psychosocial Support. Nebulized Levofloxacin For Chronic P aeruginosa infection. Results. Results (cont). Depression and Anxiety in Patients With CF. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/1.jpg)
Research Advances in Cystic Fibrosis
Expert Interpretations and Clinical Insights
![Page 2: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/2.jpg)
Data on Nebulized Levofloxacin and Guidance on Psychosocial
Support
![Page 3: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/3.jpg)
Nebulized Levofloxacin For Chronic P aeruginosa infection
![Page 4: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/4.jpg)
Results
![Page 5: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/5.jpg)
Results (cont)
![Page 6: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/6.jpg)
Depression and Anxiety in Patients With CF
![Page 7: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/7.jpg)
Best Practice Guidelines: Psychosocial Support
![Page 8: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/8.jpg)
Best Practice Guidelines: Psychosocial Support (cont)
![Page 9: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/9.jpg)
Key Transition Points
![Page 10: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/10.jpg)
An Update on Ivacaftor and the Evolving Role of MRI
![Page 11: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/11.jpg)
Background
![Page 12: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/12.jpg)
KONDUCT Study
![Page 13: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/13.jpg)
KONDUCT Study (cont)
![Page 14: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/14.jpg)
Additional Findings
![Page 15: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/15.jpg)
Additional Findings (cont)
![Page 16: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/16.jpg)
Investigators’ Conclusion
![Page 17: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/17.jpg)
MRI Detection of Lung Ventilation Defects in CF
![Page 18: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/18.jpg)
Additional Results
![Page 19: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/19.jpg)
MRI Assessment of Response to Therapy
![Page 20: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/20.jpg)
Additional Findings
![Page 21: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/21.jpg)
Take-home Points
![Page 22: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/22.jpg)
MRI Evaluation of Pulmonary Blood Flow
![Page 23: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/23.jpg)
Take-home Point
![Page 24: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/24.jpg)
Recommendations For Exercise and For CFTR Modulator Therapy
![Page 25: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/25.jpg)
The Importance of Exercise in CF
![Page 26: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/26.jpg)
Results
![Page 27: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/27.jpg)
Best Practices: CFTR Modulator Therapy
![Page 28: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/28.jpg)
Best Practices: CFTR Modulator Therapy (cont)
![Page 29: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/29.jpg)
Best Practices: CFTR Modulator Therapy (cont)
![Page 30: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/30.jpg)
The Ronan et al Study
![Page 31: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/31.jpg)
Does Ivacaftor Improve Lung Function By Altering Airway
Microbiology?
![Page 32: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/32.jpg)
Effect of Ivacaftor on Mucociliary Clearance
![Page 33: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/33.jpg)
KONNECTION Study
![Page 34: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/34.jpg)
Results
![Page 35: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/35.jpg)
Take-home Points
![Page 36: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/36.jpg)
New Findings on Inhaled Antibiotic Therapies
![Page 37: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/37.jpg)
Once-daily Inhaled Liposomal Amikacin
![Page 38: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/38.jpg)
Study Design
![Page 39: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/39.jpg)
Highlights of Efficacy Results
![Page 40: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/40.jpg)
Highlights of Efficacy Results (cont)
![Page 41: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/41.jpg)
Highlights of Safety Results
![Page 42: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/42.jpg)
Take-home Point
![Page 43: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/43.jpg)
Incorporating a Third Inhaled Antipseudomonal Antibiotic Class
![Page 44: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/44.jpg)
Highlights of Results
![Page 45: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/45.jpg)
Highlights of Results (cont)
![Page 46: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/46.jpg)
Abbreviations
![Page 47: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/47.jpg)
References
![Page 48: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/48.jpg)
References (cont)
![Page 49: Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights](https://reader035.vdocuments.us/reader035/viewer/2022062811/56815ff6550346895dcef388/html5/thumbnails/49.jpg)
References (cont)